期刊名称：CLINICAL ONCOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
To order this journal online, visit http://www.elsevierhealth.com/journals/clon Clinical Oncology is an International
cancer journal covering all aspects of the clinical management of cancer patients, reflecting a multidisciplinary approach to therapy.
Papers, editorial and reviews are published on all types of malignant disease embracing, pathology, diagnosis and treatment, including radiotherapy, chemotherapy, surgery, combined modality treatment and palliative care. Research and review papers covering epidemiology, radiobiology, radiation, physics, tumour biology, and immunology are also published, together with letters to the editor, case reports and book reviews.
Clinical Oncology is for all those with an active interest in the treatment of cancer.
Instructions to Authors
Original Articles and Review Articles conforming to the Journal's aims should be submitted to:
Dr P. J. Hoskin, Editor
Marie Curie Research Wing for Oncology Mount Vernon Hospital
Rickmansworth Road
Northwood
Middlesex HA6 2RN
UK
Manuscripts from North America, conforming to the Journal's aims, should be submitted to:
Professor Mary Gospodarowicz
Ontario Cancer Institute
Princess Margaret Hospital
610 University Avenue
Toronto
Ontario MSG 2MP
Canada
Reviews should be prefaced by a statement detailing the search strategies used and sources of information.
Case Reports will only be accepted if considered to be of particular interest or merit. These should be limited to 4 manuscript pages, no more than 2 illustrations and no more than 6 references.
Correspondence to the Editor will be published if it is deemed of sufficient interest and relevance. Priority will be given to letters relating to articles previously published in Clinical Oncology, but also including other comment on matters of interest to oncologists and interesting case reports. Letters should be no longer than 500 words, and, in exceptional circumstances, may include one table of data. Figures will not usually be published in this section. Letters should be signed by all authors and the usual conditions of copyright and sole submission will apply. Letters are not subject to peer review and are accepted at the discretion of the Editor on this basis.
Papers must be submitted exclusively to the Journal on the understanding that they have not been and will not be published elsewhere. The main author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the authors' responsibility to obtain and supply written permission for the reproduction of any tables, illustrations or quotations of more than 25 words that have been published elsewhere. Authors must describe any direct or indirect financial interest they have in the subject matter of a submitted manuscript. Papers accepted by the Journal become the copyright of the Royal College of Radiologists. This Journal supports the COPE Guidelines for publication in Medical Research. Refer to Clinical Oncology 2000;12:206-212.
Informed Consent Manuscripts reporting the results of studies in human subjects must include a statement to the effect that informed consent and ethical approval had been obtained.
Preparation The original and 3 copies should be submitted accompanied by 3 sets of illustrations. Papers should be typed double spaced on A4 paper on one side only. Pages should be numbered consecutively. Figure legends and tables should be grouped together at the end of the manuscript on separate sheets. Any provisionally accepted paper which is resubmitted more than 12 months after being sent back for revision will be treated as a new submission.
Electronic Submissions Final manuscripts only should be accompanied by a copy on an IBM-compatible disk.
Title page This should carry the complete title of the manuscript, initial(s) and surname(s) of all authors with the affiliation and address of each author cross-referenced to the appropriate name. A separate name and address for correspondence should be given including telephone, fax and email addresses.
Text The main body of the text should be preceded by an Abstract of no more than 300 words, followed by up to 6 Keywords, placed in alphabetical order. The text itself should contain an Introduction, stating the purpose of the study, followed by Methods, Results, Discussion, Acknowlegements and References.
Abbreviations should be used only where appropriate, and the full term should be given first. Non-proprietary (generic) names of products should be used. If a brand name of a drug is used, the British or International non-proprietary (approved) name should be given. The source of any new or experimental preparation should also be given.
Units/Symbols Scientific measurements should be given in SI units. For guidance and conversion factors, see SI for the Health Professions (WHO, 1977).
Statistical Methods should be defined in the Methods section of the paper, and any not in common use should be either described in detail or supported by references. Refer to Clinical Oncology 2000;12: 202-205.
Tables should be typed on separate sheets and numbered consecutively in the text.
Illustrations Original line drawings and graphs (not photocopies) should be submitted in a form suitable for immediate reproduction. Any halftone illustrations (photographs) must be of top quality to ensure good and accurate reproduction, with any lettering and detail large enough to ensure reduction to minimum 78 mm width. On the back of each figure the figure number should be written in red and an arrow drawn to indicate the top edge. Clinical photographs and other material should be anonymous and a statement confirming patient consent to publication included with the manuscript. Normally no more than 6 illustrations will be accepted. A limited number of colour illustrations may be included.
References The accuracy of the references is the authors' responsibility. References should be numbered consecutively as they appear in the text, using Arabic numerals in square brackets. "Unpublished observations" and "personal communications" must not be included in the reference list. References can only be designated 'in press' if the article has been accepted for publication. At the end of the article, references should be listed in numerical order, following the style of the examples below. Titles of journals should be abbreviated according to the style of Index Medicus. When seven or more authors are listed, only the first threenames should be cited.
Standard journal article: Aviles A, Alatriste S, Talevera A, et al. Alternating combination chemotherapy and interferon improves survival in poor prognosis multiple myeloma. Clin Oncol 1995;7:97-101.
Book: Chamberlain J, Moss S (editors). Evaluation of cancer screening. London, Springer, 1995.
Chapter in a book: Tannock IF. Cell kinetics and cancer chemotherapy. In: Hellman K, Carter SK, editors. Fundamentals of cancer chemotherapy. New York: McGraw-Hill, 1987:7-19.
Digital Object Identifier WB Saunders assigns a unique digital object identifier (DOI) to every article it publishes. The DOI appears on the title page of the article. It is assigned after the article has been accepted for publication and persists throughout the lifetime of the article. Due to its persistence, it can be used to query WB Saunders for information on the article during the production process, to find the article on the Internet through various Web sites, including IDEAL, and to cite the article in academic references. When quoting articles which are published online in a reference section, it is important to include the article's DOI in the reference as volume and page information is not always available for articles published online. The References section, below, shows samples of DOI included in references. Further information may be found at http://www.academicpress.com/doi.
Please note the following examples:
Nanduri B, Zimniak P. Indications for hematology. Eur Heart J 1999; 362: 167-174, doi: 10.1053/euhj.1998.1009.
Prasad R K, Ismail-Beigi F. Indications for hematology. Eur Heart J doi: 10.1053/euhj.1998.1026.
Editorial Board
-
- Editor:
- P.J. Hoskins, Mount Vernon Hospital, Middlesex, UK
- Regional Editor:
- J.W. Denham (Australasia), Newcastle University, Newcastle, Australia
M. Gospodarowicz (North America), Princess Margaret Hospital, Toronto, Canada
F.D. Patel (Asia), PGIMER, Chandigarh, India
- Assistant Editors:
- G.C.W. Howard
J.T. Roberts
- Editorial Board:
- J.M. Brown
J. Dunn
D. Dodwell
K.C.H. Fearon
J. Graham
D. Hirst
J.K. Joffe
P.W.M. Johnson
P. Kirkbride
D. Lawrence
A. Lessells
H. Lucraft
W.P. Makin
B. Morland
M. O'Brien
J. Paul
G. Read
N.P. Rowell
R.P. Symonds
| 
